Dialogues in Cardiovascular Medicine - Vol 9 . No. 3 . 2004



Metabolic Syndrome




Role of sympathetic overactivity in the pathophysiology of the metabolic syndrome
B. M. Egan, S. Julius




Metabolic syndrome: what are the acknowledged markers, and how reliable are they?
I. Zavaroni, D. Ardigò, S. Valtueña, A. Dei Cas


Metabolic syndrome and hypertension: what are the outstanding problems?
M. D. Esler


By which mechanisms does leptin contribute to elevated blood pressure?
M. L. G. Correia, K. Rahmouni, A. Mark




Icons of Cardiology: Raymond Vieussens and the “first” pathophysiological description of heart failure
A. M. Katz




A. Brackenridge, D. Russell-Jones


Autonomic nervous cardiovascular regulation in borderline hypertension
S. Julius and M. Esler

Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR)
E. Ferrannini and others

State-of-the-art lecture. Obesity-induced hypertension: new concepts from the emerging biology of obesity
A. L. Mark and others

Adrenergic and reflex abnormalities in obesity-related hypertension
G. Grassi and others

Impact of overweight on the risk of developing common chronic diseases during a 10-year period
A. E. Field and others
Sympathetic nervous system and insulin resistance: from obesity to diabetes
M. Esler and others

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey
E. S. Ford and others

Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome
B. Balkau and others

The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
H. M. Lakka and others

The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994
Y. W. Park and others




© 2008 LES LABORATOIRES SERVIER, an incorporated company of SERVIER All Rights Reserved - Updates